MIT Technology Review November 13, 2024
Jean-Philippe Vert, PhD

Embracing the paradigm shift of agentic AI could lead to massive advancements in healthcare as we know it.

The complexity of biology has long been a double-edged sword for scientific and medical progress. On one hand, the intricacy of systems (like the human immune response) offers countless opportunities for breakthroughs in medicine and healthcare. On the other hand, that very complexity has often stymied researchers, leaving some of the most significant medical challenges—like cancer or autoimmune diseases—without clear solutions.

The field needs a way to decipher this incredible complexity. Could the rise of agentic AI, artificial intelligence capable of autonomous decision-making and action, be the key to breaking through this impasse?

Agentic AI is not just another tool in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Biotech startups are built on venture capital. Track funding rounds here.
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?

Share This Article